[ad_1]
The Wisconsin Division of Well being Companies has entered right into a contract with publicly-traded firm Pear Therapeutics to supply its reSET and reSET-O prescription digital therapeutics to Wisconsin residents with substance use dysfunction and opioid use dysfunction.
Pear’s reSET, a cell utility used to assist deal with substance use dysfunction, acquired FDA De Novo clearance in 2017. The Boston-based firm’s reSET-O acquired 510(ok) clearance in 2018.
Wisconsin’s DHS will make reSET and reSET-O accessible by taking part suppliers inside outpatient remedy settings, together with applications that supply prescriptions for buprenorphine, a drugs that can be utilized to deal with opioid dependence.
Pear tells MobiHealthNews, “[The deal] will present underserved populations in various demographics and areas throughout the state with entry to reSET and reSET-O.”
THE LARGER TREND
Pear wasn’t proof against the layoffs many digital well being corporations noticed this previous summer season.
In July, Pear laid off roughly 25 of its workers, making up about 9% of its full-time workforce as a result of bigger financial setting and the necessity to restructure operations to slim its short-term enterprise focus. In an SEC submitting, Pear famous the discount will minimize working bills by $28 million over 18 months, extending its money runway.
The layoff announcement got here three months after Pear launched a program to supply its reSET and reSET-O choices through telehealth suppliers, with the primary being Pursue Care, which focuses on dependancy drugs.
Source link